ORL-HNS department,Mansoura University Hospital, Faculty of Medicine, Mansoura University
Al Mansurah, ElDakahlia, 35516, Egypt
NCT Number: NCT03922295
Aim of this study is to compare results of double and single flap techniques for tympanoplasty in chronic suppurative otitis media patients. Inclusion criteria include total or subtotal tympanic membrane perforations with limited anterior remnant and should be dry for at least 3 months. Patients with persistent discharge, cholesteatoma, ossicular affection or those with recurrent perforations after previous myringoplasty were excluded. Also, patients with uncontrolled diabetes, chronic liver and kidney diseases and immuno-compromised patients are not included in this study. Patients are divided into two groups, endoscopic double flap group and endoscopic single flap group. Healing and hearing outcomes were evaluated 3 months postoperative. Also, post-operative pain scores and complications were assessed.
Looking for future studies?
Notify Me18 year–50 year
All sexes
Interventional
Not applicable
Al Mansurah, ElDakahlia, 35516, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In the double flap group, graft is placed via elevation of both posterior and anterior flaps.
In the single flap group, graft is placed via elevation of posterior flap only
Time frame: 3 months after surgery
closure of tympanic membrane perforation
Mansoura University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07698171
Ear Diseases, Myringoplasty
Holon, Israel
View Trial DetailsNCT07535827
Ear Diseases, Glucose Metabolism Disorders
Minya, Egypt
View Trial DetailsNCT07595484
Chronic Otitis Media, Ear Diseases
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT06083181
Ear Diseases, Otorhinolaryngologic Diseases
Los Angeles, California, United States
View Trial Details